Asia stocks reversed early gains on Tuesday, with traders sidelined ahead of U.S. inflation data and a European monetary policy…
The approval by U.S. regulators on Monday of a Biogen Inc (BIIB.O) drug to treat Alzheimer's disease could reinvigorate investor…
U.S. regulators on Monday approved Biogen Inc's (BIIB.O) aducanumab as the first treatment to attack a likely cause of Alzheimer's…